July 28 (SeeNews) - The tender for the sale of 25% stake in indebted Serbian state-controlled drug maker Galenika has attracted three bids - from India's Cadila Pharmaceuticals, Brazil's biggest pharmaceutical firm EMS S.A., and a consortium of Britain's Frontier Pharma Limited and Russian LLC NPA Petrovax Pharm, the country's economy ministry said.